These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7871123)

  • 21. Disorganization and cognitive impairment in schizophrenia: independent symptom dimensions?
    Klingberg S; Wittorf A; Wiedemann G
    Eur Arch Psychiatry Clin Neurosci; 2006 Dec; 256(8):532-40. PubMed ID: 17164977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emotional response as a function of symptoms in schizophrenia.
    Quirk SW; Strauss ME; Sloan DM
    Schizophr Res; 1998 Jun; 32(1):31-9. PubMed ID: 9690332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are there valid subtypes of schizophrenia? A grade of membership analysis.
    Pomarol-Clotet E; Salvador R; Murray G; Tandon S; McKenna PJ
    Psychopathology; 2010; 43(1):53-62. PubMed ID: 19940542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychopathological dimensions in schizophrenia.
    Cuesta MJ; Peralta V
    Schizophr Bull; 1995; 21(3):473-82. PubMed ID: 7481577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Theory of mind in schizophrenia: the role of clinical symptomatology and neurocognition in understanding other people's thoughts and intentions.
    Abdel-Hamid M; Lehmkämper C; Sonntag C; Juckel G; Daum I; Brüne M
    Psychiatry Res; 2009 Jan; 165(1-2):19-26. PubMed ID: 19073346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia.
    Xu K; Krystal JH; Ning Y; Chen DC; He H; Wang D; Ke X; Zhang X; Ding Y; Liu Y; Gueorguieva R; Wang Z; Limoncelli D; Pietrzak RH; Petrakis IL; Zhang X; Fan N
    J Psychiatr Res; 2015 Feb; 61():64-72. PubMed ID: 25560772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Identification by typological analysis of distinct groups of schizophrenic patients. Applicability of a disorganized schizophrenia subtype].
    Brazo P; Ribeyre JM; Petit M; Dollfus S
    Encephale; 1996; 22(3):165-74. PubMed ID: 8767044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonverbal social perception and symptomatology in schizophrenia.
    Toomey R; Schuldberg D; Corrigan P; Green MF
    Schizophr Res; 2002 Jan; 53(1-2):83-91. PubMed ID: 11728841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impairment in test performance and symptom dimensions of schizophrenia.
    Eckman PS; Shean GD
    J Psychiatr Res; 2000; 34(2):147-53. PubMed ID: 10758257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing positive and negative symptoms in children and adolescents.
    Fields JH; Grochowski S; Lindenmayer JP; Kay SR; Grosz D; Hyman RB; Alexander G
    Am J Psychiatry; 1994 Feb; 151(2):249-53. PubMed ID: 8296898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity in schizophrenia: an extended replication of the hebephrenic-like and paranoid-like subtypes.
    Williams J; Farmer AE; Wessely S; Castle DJ; McGuffin P
    Psychiatry Res; 1993 Dec; 49(3):199-210. PubMed ID: 8177916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical dimensions of auditory hallucinations in schizophrenic disorders.
    Oulis P; Gournellis R; Konstantakopoulos G; Matsoukas T; Michalopoulou PG; Soldatos C; Lykouras L
    Compr Psychiatry; 2007; 48(4):337-42. PubMed ID: 17560954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factorial structure of the Scale of Prodromal Symptoms.
    Hawkins KA; McGlashan TH; Quinlan D; Miller TJ; Perkins DO; Zipursky RB; Addington J; Woods SW
    Schizophr Res; 2004 Jun; 68(2-3):339-47. PubMed ID: 15099615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new five factor model of schizophrenia.
    Lindenmayer JP; Bernstein-Hyman R; Grochowski S
    Psychiatr Q; 1994; 65(4):299-322. PubMed ID: 7831416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life.
    Ho BC; Nopoulos P; Flaum M; Arndt S; Andreasen NC
    Am J Psychiatry; 1998 Sep; 155(9):1196-201. PubMed ID: 9734542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between the major psychoses.
    Maziade M; Roy MA; Martinez M; Cliche D; Fournier JP; Garneau Y; Nicole L; Montgrain N; Dion C; Ponton AM
    Am J Psychiatry; 1995 Oct; 152(10):1458-63. PubMed ID: 7573584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using the rating scale for psychotic symptoms to characterize delusions expressed in a schizophrenia patient with "Internet psychosis".
    Margolese HC; Chouinard G; Beauclair L; Miller R
    Can J Psychiatry; 2002 Jun; 47(5):485. PubMed ID: 12085686
    [No Abstract]   [Full Text] [Related]  

  • 39. Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale.
    Bell MD; Lysaker PH; Beam-Goulet JL; Milstein RM; Lindenmayer JP
    Psychiatry Res; 1994 Jun; 52(3):295-303. PubMed ID: 7991723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive and negative symptoms of schizophrenia: past, present, and future.
    Andreasen NC; Nopoulos P; Schultz S; Miller D; Gupta S; Swayze V; Flaum M
    Acta Psychiatr Scand Suppl; 1994; 384():51-9. PubMed ID: 7879644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.